(Given the potential long-term consequences of NMOSD relapses, the company could not ethically include a direct placebo arm in its Phase III trial.) Ultomiris was well-tolerated overall, and most treatment-emergent events were mild or moderate in severity, according to AstraZeneca
This category includes psyllium husk, beta-glucan from oats, pectin from fruits, and guar gum
Potential interactions with insulin and other antidiabetic agents should be considered
The safety and effectiveness of FARXIGA have not been established in pediatric patients to reduce the risk of [see Indications and Usage (1)]: sustained eGFR decline, end-stage kidney disease, CV death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression
CA$ 49.86 You save CA$ 2.62